Healthcare


 ASX biotech companies creating a pandemic-free buzz!

ASX biotech companies creating a pandemic-free buzz!

June 21, 2020 12:00 AM AEST| By Team Kalkine Media

As on 19 June 2020, the “pneumonia-like” illness has taken 456,432 lives with 8,538,928 confirmed cases recorded worldwide.  And with no sign to the ending of this human loss, an indispensable need for a vaccine or a treatment has .....

 Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and API

Are Investors Buying these Healthcare Stocks: Starpharma, Sigma and API

June 16, 2020 06:57 PM AEST| By Team Kalkine Media

The healthcare sector is a significant and complex sector comprising a variety of companies engaged in manufacturing, developing, and selling of medical devices, drugs, and services. The healthcare system in Australia is one of the most robust ones.....

 Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovation, Boost R&D Efforts

Don’t Miss! Small-Cap Healthcare Players’ Continued Focus on Innovation, Boost R&D Efforts

June 12, 2020 02:49 PM AEST| By Team Kalkine Media

In the healthcare world, the general trend has been that smaller biotech players work on the innovation angle with research and development activities, while the more prominent players handle the marketing and commercialisation activities as they h.....

 3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1

3 Small-cap Healthcare Stocks to Watch Out For – IMM, IDX, AT1

June 11, 2020 02:53 PM AEST| By Team Kalkine Media

Small-cap stocks are listed companies with market capitalisation varying from USD 300 million to USD 2 billion or less. And in these stocks, there are plenty of promising investment opportunities. Despite their smaller size, small-cap stocks have s.....

 Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASCO 2020 Annual Meeting

Noxopharm Presented Highly Encouraging Veyonda® Clinical Data at ASCO 2020 Annual Meeting

June 03, 2020 11:42 AM AEST| By Team Kalkine Media

Summary Noxopharm presented two sets of clinical data concerning the development of Veyonda® as a treatment for end-stage prostate cancer at ASCO 2020 Annual Meeting. Highly encouraging interim data from the Phase 1b/2a LuPIN clinical trial.....

 Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2 Million

Prescient Reports March 2020 Quarterly Update; Cash Reserves at $8.2 Million

April 17, 2020 01:14 PM AEST| By Team Kalkine Media

Australian based clinical-stage Oncology company Prescient Therapeutics Limited (ASX:PTX), recently reported operating highlights and financial outcomes for the March quarter 2020. The Company is engaged in the development of new drugs that demonstr...

 Lens over SUDA’s Operational Highlights in 1H FY20

Lens over SUDA’s Operational Highlights in 1H FY20

March 04, 2020 01:59 PM AEDT| By Hina Chowdhary

Continuing its practice of delivering solid operational results, oro-mucosal drug delivery firm SUDA Pharmaceuticals Ltd (ASX:SUD) has recently declared results for the half-year period ended 31st December 2019. The Company continued to focus on attr...

 A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx

A Smash Hit by Imugene: Received Core US Patent for HER-Vaxx

January 15, 2020 04:50 PM AEDT| By Hina Chowdhary

It’s surely a prosperous new year for the clinical-stage immuno-oncology player, Imugene Limited (ASX:IMU) that has received core US patent in the largest pharmaceutical market of the world. The United States Patent and Trademark Office (USPTO...

 Prescient Collaborates with Carina Biotech in Expansion into Exciting CAR-T Therapies

Prescient Collaborates with Carina Biotech in Expansion into Exciting CAR-T Therapies

December 10, 2019 04:19 PM AEDT| By Team Kalkine Media

Prescient Therapeutics Limited (ASX: PTX) develops personalised medicine approaches to address mutations that cause cancer. The Company employs a targeted therapy approach to target individual tumour variability rather than the conventional one size...

 Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

Health Care Stocks In Red Zone Today: Mayne, PolyNovo, Nanosonics

November 25, 2019 06:06 PM AEDT| By Team Kalkine Media

Health care sector is one of the most significant contributors to the Australian economy, known for delivering best services by advancing technology. Health care sector comprises of providers of medical services, medical insurance, and medical equip...

 A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

A Deep Dive into Imugene’s Opportunities in the Immuno-oncology Market

August 20, 2019 04:36 PM AEST| By Team Kalkine Media

Imugene Limited (ASX: IMU) is a clinical stage biotechnology company that focuses on the development of immunotherapies that have the potential to enable a patient?s immune system to recognise and destroy cancer cells. The company is focused on targe...

 Journey of Prescient Therapeutics in 2019

Journey of Prescient Therapeutics in 2019

July 25, 2019 12:38 PM AEST| By Team Kalkine Media

Prescient Therapeutics Limited (ASX: PTX) is a clinical-stage oncology company that works on mutation causing cancer. The existing product portfolio of the company includes two drug candidates, PTX 100 and PTX 200, under the development phase. Both...

 Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ Drug

Noxopharm Eyes The Development Of A Well-Tolerated ‘STING agonist’ Drug

July 24, 2019 04:54 PM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) has released July 2019 edition of its Newsletter called 'Versatility'. The clinical-stage drug development company, Noxopharm reports on the progress of its lead anti-cancer drug candidate Veyonda? achieved over the past...

 An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials

An Overview Of IMU’s B-Cell Vaccines’ Clinical Trials

July 22, 2019 07:22 PM AEST| By Team Kalkine Media

An Australian-based biotechnology company, Imugene Limited (ASX: IMU) focuses on the development of cancer immunotherapies targeted at activating the immune system of cancer patients. The company?s exceptional platform technology helps in stimulating...

 A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy

A Look at Imugene’s robust pipeline of B-Cell Vaccines for Cancer Immunotherapy

June 28, 2019 04:36 PM AEST| By Team Kalkine Media

An Australian-headquartered clinical stage immuno-oncology company, Imugene Limited (ASX: IMU) has a robust pipeline of B cell vaccines aimed at treating a variety of cancers. The company?s pipeline includes multiple product candidates that are used...

 AFP’s FY19 Performance - What investors need to know?

AFP’s FY19 Performance - What investors need to know?

May 23, 2019 01:50 PM AEST| By Team Kalkine Media

AFT Pharmaceuticals Limited (ASX: AFP) is a growing pharma company with its head office based out of New Zealand. It officially was listed on ASX in December 2015. On 22nd May 2019, the company published its Investor Presentation and Annual Report, c...

 Kazia Therapeutics collaborates with Alliance to investigate new drug, GDC-0084

Kazia Therapeutics collaborates with Alliance to investigate new drug, GDC-0084

May 21, 2019 01:42 PM AEST| By Team Kalkine Media

Kazia Therapeutics Limited (ASX: KZA) caters to the health care sector and is based out of Sydney, Australia. It is a bio-tech company which focusses on innovative oncology. The company aims to bring out diversified portfolio of new cancer therapies....

 GMV executes two Provider Participation Agreements with United States-based companies

GMV executes two Provider Participation Agreements with United States-based companies

May 16, 2019 04:09 PM AEST| By Team Kalkine Media

G Medical Innovations Holdings Limited (ASX: GMV) is a healthcare company focused on digital health solutions. On 16 May 2019, GMV reported that its wholly owned subsidiary G Medical Diagnostic Services Inc (GMEDx) had executed two Provider Particip...

 Looking Through The Business Model Of This Drug Development Company – Noxopharm

Looking Through The Business Model Of This Drug Development Company – Noxopharm

May 10, 2019 12:06 PM AEST| By Team Kalkine Media

Noxopharm Limited (ASX: NOX) rides on its overarching objective for a treatment ?to harness the body?s immune system to attack all the cancer cells in the body, but with noticeably reduced side-effects. The company is positioned as a clinical-stage d...

 Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited

Respiri to Enter Indian Market; Announces JV with MedAchievers Private Limited

May 03, 2019 04:17 PM AEST| By Team Kalkine Media

Today, on 3rd May 2019, Respiri Limited (ASX: RSH) announces a Joint Venture Agreement for the company?s entry into India with MedAchievers Private Limited, which is an integrated platform for global healthcare, led by Dr Harsha Vardhan, Founder and...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.